We are live on ! Find out more
LUCD icon

Lucid Diagnostics
LUCD

72 hedge funds and large institutions have $21.9M invested in Lucid Diagnostics in 2025 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

256% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 9

217% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 6

55% more capital invested

Capital invested by funds: $14.1M → $21.9M (+$7.78M)

47% more funds holding

Funds holding: 49 → 72 (+23)

6.71% more ownership

Funds ownership: 10.81% → 17.52% (+6.7%)

Holders
72
Holders Change
+23
Holders Change %
+46.94%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
32
Increased
19
Reduced
6
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$4.64M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$4.18M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.65M
4
State Street
State Street
Massachusetts
+$747K
5
Northern Trust
Northern Trust
Illinois
+$630K

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.48M
2
GCM
Ghisallo Capital Management
Massachusetts
-$629K
3
SS
Sunbelt Securities
Texas
-$387K
4
Millennium Management
Millennium Management
New York
-$304K
5
Renaissance Technologies
Renaissance Technologies
New York
-$279K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$4.75M +$4.18M +3,238,404 +364%
BlackRock
2
BlackRock
New York
$4.16M +$4.64M +3,591,013 +13,149%
MCM
3
Masters Capital Management
Georgia
$3.14M – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$1.81M +$1.65M +1,274,194 +420%
LM
5
Luminus Management
Texas
$914K +$437K +338,186 +74%
Alyeska Investment Group
6
Alyeska Investment Group
Illinois
$849K -$1.48M -1,149,566 -61%
State Street
7
State Street
Massachusetts
$717K +$747K +578,087 +1,285%
Northern Trust
8
Northern Trust
Illinois
$609K +$630K +487,639 +1,167%
Morgan Stanley
9
Morgan Stanley
New York
$537K +$459K +355,040 +318%
Lido Advisors
10
Lido Advisors
California
$441K – – –
First Manhattan
11
First Manhattan
New York
$372K +$401K +310,850 +2,467%
Goldman Sachs
12
Goldman Sachs
New York
$355K +$287K +222,376 +258%
Renaissance Technologies
13
Renaissance Technologies
New York
$280K -$279K -215,786 -47%
N
14
Nuveen
North Carolina
$280K +$314K +243,274 New
Wells Fargo
15
Wells Fargo
California
$261K +$290K +224,710 +10,452%
XF
16
XML Financial
Maryland
$206K – – –
Charles Schwab
17
Charles Schwab
California
$201K +$226K +174,868 New
Bank of New York Mellon
18
Bank of New York Mellon
New York
$180K +$203K +156,872 New
Barclays
19
Barclays
United Kingdom
$138K +$153K +118,418 +7,476%
GAM
20
Gotham Asset Management
New York
$136K +$666 +516 +4%
Squarepoint
21
Squarepoint
New York
$129K +$106K +81,713 +268%
NCM
22
Nantahala Capital Management
Connecticut
$109K – – –
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$97.1K -$137K -106,013 -56%
New York State Common Retirement Fund
24
New York State Common Retirement Fund
New York
$96.7K +$109K +84,100 New
Deutsche Bank
25
Deutsche Bank
Germany
$87.7K +$98.5K +76,301 New
1
2 3 4

LUCD Hedge Fund Activity: Q2 2025 in Review

72 of the 7,598 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q2 2025, worth a combined $21.9M — up 55% from $14.1M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new LUCD positions and 9 closed out — a net gain of 23 holders — while 19 added to existing stakes and 6 trimmed.

The largest buyer was BlackRock, adding an estimated $4.64M. The largest seller was Alyeska Investment Group, cutting an estimated $1.48M.

  • 72 institutional investors held Lucid Diagnostics (LUCD) as of Q2 2025, up from 49 in Q1 2025.
  • Funds reported $21.9M of Lucid Diagnostics stock for Q2 2025, up 55% quarter-over-quarter.
  • 32 funds opened new Lucid Diagnostics positions in Q2 2025 and 9 closed out, a net change of +23 holders.
  • The largest Lucid Diagnostics buyer in Q2 2025 was BlackRock, an estimated $4.64M added.
  • The largest Lucid Diagnostics seller in Q2 2025 was Alyeska Investment Group, an estimated $1.48M sold.

Based on aggregated 13F filings for Q2 2025.